elara semaglutide Physician-Guided GLP-1 Weight Loss Elara Telehealth | Women's Wellness
Description
The 0.25mg starting dose of semaglutide triggers meaningful weight loss in most patients within the first 4-8 weeks
A group of medications called GLP-1 agonists, originally used for diabetes, may help protect kidneys and improve heart health
The first study shows that more economical and sustainable weight loss can be maintained by inducing subjects with tirzepatide and changing to oral orforglipron for the long term

Semaglutide remains detectable in your body for several weeks after your last injection, but appetite suppression typically fades within days
Force Factor Super GLP-1 Support does not contain GLP-1 or synthetic GLP-1 and is not designed to replace GLP-1 medication. Consult a healthcare professional before discontinuing use of GLP-1 medication. *In a clinical study by Ribeiro et al. (2019), adults with elevated blood sugar levels taking 200mg of Eriomin per day saw a significant improvement of 15.6% in GLP-1 levels by week 12, compared to a 0.2% increase in the placebo group. **In a clinical study by Kaats et al. (1996), subjects who took Chromax Chromium Picolinate showed an improvement in body composition scores, percent body fat, and weight compared to placebo, in conjunction with a regular diet and exercise program. All ingredient amounts listed are per serving. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease
